LLY logo Eli Lilly and Company +
Eli Lilly and Company
+

Eli Lilly and Company (LLY) Business News

Track Eli Lilly and Company in real time with a live news feed covering Eli Lilly and Company stock news, official press releases, company announcements, and an archive of historical Eli Lilly and Company news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
8:17 AM | Monday | May 18, 2026 Proactive Investors

Novo Nordisk's Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says

NEW News Thumbnail
1:00 AM | Sunday | May 17, 2026 The Motley Fool

Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound?

News Thumbnail
1:00 AM | Sunday | May 17, 2026 The Motley Fool

Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound?

News Thumbnail
11:00 AM | Saturday | May 16, 2026 PRNewsWire

Lilly, Caitlin Clark Foundation, and Musco Lighting open three community sports courts in Indianapolis, expanding year-round access for youth

News Thumbnail
12:31 PM | Friday | May 15, 2026 Zacks Investment Research

BIIB Advances Alzheimer's Disease Drug Despite Study Missing Main Goal

News Thumbnail
10:00 AM | Friday | May 15, 2026 Zacks Investment Research

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

News Thumbnail
7:00 AM | Thursday | May 14, 2026 PRNewsWire

Lilly and UNICEF collaborate to give millions of children a healthier start

News Thumbnail
12:52 PM | Wednesday | May 13, 2026 Zacks Investment Research

Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead

News Thumbnail
11:33 AM | Wednesday | May 13, 2026 Benzinga

Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss

News Thumbnail
5:28 AM | Wednesday | May 13, 2026 Reuters

Eli Lilly launches Alzheimer's drug Donanemab in India

News Thumbnail
12:00 PM | Tuesday | May 12, 2026 PRNewsWire

In honor of its 150th anniversary, Eli Lilly and Company commits to support community organizations aiming to provide 500,000 meals and cold storage for 150 food pantries

News Thumbnail
11:25 AM | Tuesday | May 12, 2026 24/7 Wall Street

Eli Lilly Price Prediction: This Is Where The Stock Will End This Year

News Thumbnail

Novo Nordisk's Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says

Proactive Investors

8:17 AM | Monday | May 18, 2026

news photo
Loading...

Novo Nordisk's (NYSE:NVO) oral version of its blockbuster weight-loss drug Wegovy continues to outpace its main competitor despite a slight weekly decline in prescriptions, according to Citi's latest tracking data. The bank's weekly prescription tracker, based on IQVIA data, showed Wegovy pill reaching approximately 137,000 total prescriptions in its 18th week on the US market, a 4% decline week on week.

Read full article redirect
8:17 AM | Monday | May 18, 2026

Novo Nordisk's Wegovy pill maintains strong lead over Eli Lilly rival despite weekly dip, Citi says

Proactive Investors

Novo Nordisk's (NYSE:NVO) oral version of its blockbuster weight-loss drug Wegovy continues to outpace its main competitor despite a slight weekly decline in prescriptions, according to Citi's latest tracking data. The bank's weekly prescription tracker, based on IQVIA data, showed Wegovy pill reaching approximately 137,000 total prescriptions in its 18th week on the US market, a 4% decline week on week.

Read full article arrow
NEW News Thumbnail
1:00 AM | Sunday | May 17, 2026

Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound?

The Motley Fool

After stealing the show with Zepbound, Eli Lilly could further gain an edge in the market with its latest weight loss treatment, retatrutide. In recent clinical trials, the drug has demonstrated that it can serve as a stronger diabetes and weight loss treatment than its predecessors, not to mention the competition.

Read full article arrow
News Thumbnail
1:00 AM | Sunday | May 17, 2026

Could Eli Lilly's Next Weight Loss Drug Waylay Wegovy -- and Even Zap Zepbound?

The Motley Fool

After stealing the show with Zepbound, Eli Lilly could further gain an edge in the market with its latest weight loss treatment, retatrutide. In recent clinical trials, the drug has demonstrated that it can serve as a stronger diabetes and weight loss treatment than its predecessors, not to mention the competition.

Read full article arrow
News Thumbnail
11:00 AM | Saturday | May 16, 2026

Lilly, Caitlin Clark Foundation, and Musco Lighting open three community sports courts in Indianapolis, expanding year-round access for youth

PRNewsWire

Lilly to provide park and court to the City of Indianapolis as part of its 150th anniversary celebration INDIANAPOLIS, May 16, 2026 /PRNewswire/ -- The Caitlin Clark Foundation, in partnership with Eli Lilly and Company (NYSE: LLY) and Musco Lighting, has opened three new multi-sport community courts across Indianapolis—creating year-round access to safe, high-quality spaces for youth to play. These latest court openings include two courts at Indianapolis Public Schools—Clarence Farrington and Edison School of the Arts—and a public court at the corner of E.

Read full article arrow
News Thumbnail
12:31 PM | Friday | May 15, 2026

BIIB Advances Alzheimer's Disease Drug Despite Study Missing Main Goal

Zacks Investment Research

Biogen advances Alzheimer's drug diranersen to late-stage trials after a phase II study misses its main goal but shows cognitive and biomarker gains.

Read full article arrow
News Thumbnail
10:00 AM | Friday | May 15, 2026

Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

Zacks Investment Research

Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read full article arrow
News Thumbnail
7:00 AM | Thursday | May 14, 2026

Lilly and UNICEF collaborate to give millions of children a healthier start

PRNewsWire

Six-year initiative to improve non-communicable disease prevention and care for children in low- and middle-income countries NEW YORK and INDIANAPOLIS, May 14, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and UNICEF USA announced today a collaboration aiming to improve non-communicable disease (NCD) prevention and care for children, reaching over 30 million young people and caregivers across 21 low- and middle-income countries. Marking its 150th anniversary, Lilly is committing $50 million to UNICEF USA, supporting UNICEF's efforts to strengthen primary healthcare systems to better prevent, detect and manage NCDs such as diabetes, congenital heart disease, sickle cell disease and respiratory illness in children and adolescents.

Read full article arrow
News Thumbnail
12:52 PM | Wednesday | May 13, 2026

Lilly Bets on Next-Generation Obesity Drugs to Stay Ahead

Zacks Investment Research

LLY expands beyond tirzepatide with oral obesity pills and next-gen drugs like retatrutide to defend its lead in the booming weight-loss market.

Read full article arrow
News Thumbnail
11:33 AM | Wednesday | May 13, 2026

Eli Lilly Says Newly Approved Foundayo, Lower-Dose Zepbound Help Sustain Weight Loss

Benzinga

Eli Lilly and Co. (NYSE:LLY) on Wednesday released detailed findings from two late-stage obesity studies showing patients were able to maintain significant weight loss after switching from higher-dose injectable incretin therapies to either Foundayo or lower-dose Zepbound.

Read full article arrow
News Thumbnail
5:28 AM | Wednesday | May 13, 2026

Eli Lilly launches Alzheimer's drug Donanemab in India

Reuters

U.S.-based drugmaker Eli Lilly on Wednesday launched its Alzheimer's drug ​Lormalzi, also known as Donanemab, in ‌India.

Read full article arrow
News Thumbnail
12:00 PM | Tuesday | May 12, 2026

In honor of its 150th anniversary, Eli Lilly and Company commits to support community organizations aiming to provide 500,000 meals and cold storage for 150 food pantries

PRNewsWire

Through charitable support of HATCH, United Way Worldwide, United Way of Central Indiana and the Pacers Foundation, the initiative supports efforts to expand access to protein-rich food across communities nationwide, including the creation of infrastructure to deliver an estimated five million meals annually for years to come. INDIANAPOLIS, May 12, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an initiative to support nationwide nutritious food distribution as part of the company's 150th anniversary, through charitable support of trusted community organizations in the United States.

Read full article arrow
News Thumbnail
11:25 AM | Tuesday | May 12, 2026

Eli Lilly Price Prediction: This Is Where The Stock Will End This Year

24/7 Wall Street

Few stocks have polarized investors in 2026 like Eli Lilly (NYSE:LLY | LLY Price Prediction).

Read full article arrow
News Thumbnail